about
Oral immune therapy: targeting the systemic immune system via the gut immune system for the treatment of inflammatory bowel diseaseHost defences against Giardia lambliaLow dose native type II collagen prevents pain in a rat osteoarthritis modelOral tolerance to cancer can be abrogated by T regulatory cell inhibitionRestoring host-microbe homeostasis via selective chemoattraction of Tregs.Activation of B cells by a dendritic cell-targeted oral vaccine.Mucus properties and goblet cell quantification in mouse, rat and human ileal Peyer's patches.A baleful weed and the king of fruits: tolerance, immunity, and the microbiome.Natural T Regulatory Cells (n Treg) in the Peripheral Blood of Healthy Subjects and Subjects with Chronic Periodontitis - A Pilot Study.Heated allergens and induction of tolerance in food allergic children.Candida albicans is able to use M cells as a portal of entry across the intestinal barrier in vitro.Oral administration of a non-absorbable plant cell-expressed recombinant anti-TNF fusion protein induces immunomodulatory effects and alleviates nonalcoholic steatohepatitis.Psychological distress and salivary secretory immunity.Immunoregulatory function of PIR-A/B+ DCs in the inflammatory responses of dextran sodium sulfate-induced colitis.When myasthenia gravis is deemed refractory: clinical signposts and treatment strategies.Levels of regulatory T cells CD69(+)NKG2D(+)IL-10(+) are increased in patients with autoimmune thyroid disorders.Oral administration of non-absorbable delayed release 6-mercaptopurine is locally active in the gut, exerts a systemic immune effect and alleviates Crohn's disease with low rate of side effects: results of double blind Phase II clinical trial.
P2860
Q26768500-93148DB5-DF36-4A12-BF35-42BD662965C3Q27004155-E5126768-8A34-4A9B-8998-E30F35459267Q28387689-4C1A80A1-2EB9-4ECC-8CE1-F6F9FBCBB4E9Q33618271-D2847560-7F2E-48D6-8BF0-7B167EB115CDQ34421942-4600B38A-3A7F-420B-AF91-C7F2634639D1Q34979404-6D63F34B-56AB-49A4-9227-0FBE54F3CB07Q35073162-44E990DC-A836-470C-B944-6089B6487B64Q35887620-16FA29F5-C8ED-4CE2-87B0-3F6B216027DDQ36831361-B1D66DF7-0EBB-47B3-A767-C4F54B2CE0BAQ38112250-AB3573A2-E437-4EDC-8760-5B9DC33AFBEBQ38846387-A82EDCE8-C951-41CF-B300-24392960F05FQ39210713-C329A517-9539-4785-94FA-BEE1D225619BQ41027192-0C8C48EA-3577-4D0D-BF1C-146223724C75Q44126280-580423E3-C049-4F64-8BC0-6316768C51E6Q49280339-48E82D79-AE52-4B65-BBD2-ABEFB0B700CEQ53458246-1C0E4D16-0C7A-4717-BB4E-812DA8EE5A81Q53556158-AC401113-0AD4-4790-B822-E742D910079D
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Gut immune system and oral tolerance.
@en
type
label
Gut immune system and oral tolerance.
@en
prefLabel
Gut immune system and oral tolerance.
@en
P2860
P1476
Gut immune system and oral tolerance.
@en
P2093
José M Martín-Villa
Patricia Castro-Sánchez
P2860
P356
10.1017/S0007114512005223
P478
109 Suppl 2
P577
2013-01-01T00:00:00Z